Best Ghrp-2 5 mg and 10mg Peptides GMP Factory

pralmorelin(GHRP-2)

pralmorelin(GHRP-2)

Other names: Pralmorelin, Growth Hormone Releasing Peptide-2, GHRP-2, KP102.

GHRP-2(Growth Hormone Releasing Peptide-2) from Polypeptide.ltd is a synthetic hexapeptide Growth Hormone Releasing Peptide (GHRP) that acts on the brain and pituitary gland to produce growth hormone while also having a minor stimulatory effect on Prolactin, ACTH, and Cortisol levels. GHRP-2 is a real hGH secretagogue, which means it stimulates the body’s own hGH secretion. In research, human growth hormone has been proven to improve lean body mass and minimize adiposity (fat). GHRP-2 has been shown to be highly effective at stimulating GH production in research test subjects.

Production capacity: Provide customization

Large Factory Professional Manufacturers & Factory

Production Carried OUT Under CGMP Regulation and Trackable

ISO9001 & ISO14000

SHARE THIS

pinterest-logo 50x50 twitter logo Tumblr-LOGO 50x50 LinkedIn_logo_50x50LinkedIn_logo_50x50 LinkedIn_logo_50x50

Get a Bulk quotation

If you need a larger quantity. Please fill in the form, our BD (Business Development) will provide you with a competitive quotation.

GHRP-2 Peptide dosage calculator

Referenced Citations

[1] Bisi G, Podio V, Valetto MR, et al. Cardiac effects of hexarelin in hypopituitary adults. Eur J Pharmacol. 1999;381(1):31–38.

[2] Demers A, McNicoll N, Febbraio M, et al. Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study. Biochem J. 2004;382(pt 2):417–424.

[3] Braunwald E. Clinical efforts to reduce myocardial infarct size – the next step. J Cardiovasc Pharmacol Ther. 2011;16(3–4):349–353.

[4] Rossoni G, De Gennaro Colonna V, Bernareggi M, Polvani GL, Muller EE, Berti F. Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats. J Cardiovasc Pharmacol. 1998;32(2):260–265.

[5] Roh SG, He ML, Matsunaga N, Hidaka S, Hidari H. Mechanisms of action of growth hormone-releasing peptide-2 in bovine pituitary cells. J Anim Sci. 1997 Oct;75(10):2744-8. doi: 10.2527/1997.75102744x. PMID: 9331879.

[6] Furuta S, Shimada O, Doi N, Ukai K, Nakagawa T, Watanabe J, Imaizumi M. General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide. Arzneimittelforschung. 2004;54(12):868-80. doi: 10.1055/s-0031-1297042. PMID: 15646371.

[7] Iwase M, Kanazawa H, Kato Y, et al. Growth hormone-releasing peptide can improve left ventricular dysfunction and attenuate dilation in dilated cardiomyopathic hamsters. Cardiovasc Res. 2004;61(1):30–38.

[8] Xu X, Ding F, Pang J, et al. Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol. 2012;303(6):H703-H711.

[9] Ma Y, Zhang L, Launikonis BS, Chen C. Growth Hormone secretagogues preserve the electrophysiological properties of mouse cardiomyocytes isolated from in vitro ischemia/reperfusion heart. Endocrinology. 2012;153(11):5480–5490.

[10] Mao Y, Tokudome T, Kishimoto I, et al. Hexarelin treatment in male ghrelin knockout mice after myocardial infarction. Endocrinology. 2013;154(10):3847–3854.

[11] Granado M, Priego T, Martin AI, Villanua MA, Lopez-Calderon A. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab. 2005;288(3):E486-E492.

[12] Subiros N, Perez-Saad HM, Berlanga JA, et al. Assessment of dose-effect and therapeutic time window in preclinical studies of rhEGF and GHRP-6 coadministration for stroke therapy. Neurol Res. 2015;38(3):187–195.

Author of this article: Dr. Jean Zeng graduated from king’s college london Faculty of Life Sciences & Medicine.

Scientific Journal paper Author:

  1. T Phung

Laboratory of Animal Production, Department of Animal Science, Obihiro University of Agriculture and Veterinary Medicine, 2–11 Nishi, Inada-cho, Obihiro 080-8555, Japan

  1. N Matsunaga

Laboratory of Animal Production, Department of Animal Science, Obihiro University of Agriculture and Veterinary Medicine, 2–11 Nishi, Inada-cho, Obihiro 080-8555, Japan

  1. Xiaoxi Yan

Laboratory of Gastrointestinal Microbiology, Jiangsu Key Laboratory of Gastrointestinal Nutrition and Animal Health, College of Animal Science and Technology, Nanjing Agricultural University, 210095 Nanjing, China

  1. Ailian Lin

Laboratory of Gastrointestinal Microbiology, Jiangsu Key Laboratory of Gastrointestinal Nutrition and Animal Health, College of Animal Science and Technology, Nanjing Agricultural University, 210095 Nanjing, China

In no way does this doctor/scientist endorse or advocate the purchase, sale, or use of this product for any reason. Polypeptide.ltd has no affiliation or relationship, implied or otherwise, with this physician. The purpose of citing this doctor is to acknowledge, acknowledge and commend the exhaustive research and development work done by the scientists working on this peptide.

Author of this article:

Dr. Jean Zeng graduated from king's college london Faculty of Life Sciences & Medicine.

Scientific Journal paper Author:

Stephen C. Bain
Diabetes Research Group, Swansea University Medical School, Swansea, SA2 8PP, UK
Department of Diabetes and Endocrinology, Singleton Hospital, Swansea Bay University Health Board, Swansea, SA2 8QA, UK

In no way does this doctor/scientist endorse or advocate the purchase, sale, or use of this product for any reason. Polypeptide.ltd has no affiliation or relationship, implied or otherwise, with this physician. The purpose of citing this doctor is to acknowledge, acknowledge and commend the exhaustive research and development work done by the scientists working on this peptide.